Drug Shortage Report for 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION
Report ID | 101629 |
Drug Identification Number | 00828602 |
Brand name | LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ |
Common or Proper name | LIDOCAINE HCL 0.4% AND 5% DEXTROSE INJ |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE LIDOCAINE HYDROCHLORIDE |
Strength(s) | 50MG 4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 24 units/case |
ATC code | C01BB |
ATC description | ANTIARRHYTHMICS, CLASS I AND III |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-12-18 |
Actual start date | 2019-12-18 |
Estimated end date | 2020-01-27 |
Actual end date | 2020-01-27 |
Shortage status | Resolved |
Updated date | 2020-01-28 |
Company comments | Baxter product LIDOCAINE HYDROCHLORIDE 0.4% AND 5% DEXTROSE INJECTION (250 mL bags) is available as a substitute. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-01-28 | English | Compare |
v4 | 2020-01-27 | French | Compare |
v3 | 2020-01-27 | English | Compare |
v2 | 2019-12-19 | French | Compare |
v1 | 2019-12-19 | English | Compare |
Showing 1 to 5 of 5